[HTML][HTML] Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

H Bonilla, MJ Peluso, K Rodgers, JA Aberg… - Frontiers in …, 2023 - frontiersin.org
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

RECOVER Consortium - Frontiers in immunology, 2023 - scholars.uthscsa.edu
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

[PDF][PDF] Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

H Bonilla, MJ Peluso, K Rodgers, JA Aberg… - 2023 - scienceopen.com
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

[HTML][HTML] Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

H Bonilla, MJ Peluso, K Rodgers, JA Aberg… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

H Bonilla, MJ Peluso, K Rodgers… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.

H Bonilla, MJ Peluso, K Rodgers, JA Aberg… - Frontiers in …, 2023 - europepmc.org
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

RECOVER Consortium - Frontiers in immunology, 2023 - ohiostate.elsevierpure.com
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.

H Bonilla, MJ Peluso, K Rodgers… - Front …, 2023 - digitalcommons.providence.org
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

RECOVER Consortium - Frontiers in Immunology, 2023 - providence.elsevierpure.com
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

RECOVER Consortium - Frontiers in immunology, 2023 - einstein.elsevierpure.com
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …